Exclusive

Publication

Byline

Thermo Fisher opens customer solution center in China

Singapore, Nov. 14 -- Thermo Fisher Scientific Inc., the world leader in serving science, has announced the official opening of a Customer Solution Center in Shanghai, China. This follows the recent a... Read More


Mylan and Pfizer announce Viatris as new company name

Singapore, Nov. 14 -- Mylan N.V. and Pfizer Inc. have announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pro... Read More


Sanofi launches SOLIQUA in Singapore to treat adults with uncontrolled T2D

Singapore, Nov. 14 -- Sanofi on 13 Nov 2019, announced the launch of SOLIQUA(R), its once-daily injectable treatment which aims to relieve the burden of uncontrolled type 2 diabetes (T2D) in Singapore... Read More


Imagion Biosystems receives patent from India

Singapore, Nov. 14 -- Imagion Biosystems Limited, an Australian company dedicated to improving healthcare through the earlier detection of cancer has been issued patent #320872 from the Government of ... Read More


Yokogawa acquires nanopipette technology for life science applications

Singapore, Nov. 14 -- Japan headquartered Yokogawa Electric Corporation announces that it has acquired a nanopipette technology that was developed by BioStinger, Inc., a spin-off from the University o... Read More


NEC, VAXIMM to advance personalized neoantigen cancer vaccines

Singapore, Nov. 14 -- Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focused on developing oral T-cell immunotherapies, announced t... Read More


Duke-NUS' mobile health programme simplifies Type 2 diabetes health outcomes

Singapore, Nov. 14 -- The most economical and simple way to manage health problems can often be the most difficult to implement because they require lifestyle changes. Researchers at Duke-NUS Medical ... Read More


Philips launches AI based clinical product for aiding cognitive assessment

Singapore, Nov. 14 -- Royal Philips, a global leader in health technology has announced the U.S. debut of its new cognitive assessment platform IntelliSpace Cognition. Leveraging the power of artifici... Read More


LEO Pharma, HitGen to develop novel class of derma drugs

Singapore, Nov. 13 -- Denmark headquartered LEO Pharma A/S and China based HitGen Inc. are pleased to announce that HitGen and LEO Pharma expands their collaboration with a license to develop a novel ... Read More


Merck licenses CRISPR gene-editing technology to Evotec

Singapore, Nov. 13 -- Merck, a leading science and technology company, has announced that it has signed a license agreement providing Evotec SE access to Merck's foundational CRISPR intellectual prope... Read More